Clinical trial
Comparison of Patient Reported Disease Activity Scores Combined With Fecal Calprotectin Home Tests for Remote Monitoring of IBD Patients: a Multicenter Prospective Validation Study
NCT05886322 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Patient Reported Disease Activity Scores Combined With Fecal Calprotectin Home Tests for Remote Monitoring of IBD Patients: a Multicenter Prospective Validation Study
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 7, 2022
- Completion date
- June 30, 2024
- Enrollment
- 400 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
crohn disease, inflammatory bowel diseases, ulcerative colitis